360 Advances in New Modalities (Large Molecule, Oligos, Peptides, ADCs, Gene therapy, etc.) Product and Process Development (includes invited talks)


Description:
This session welcomes papers addressing the latest advances in the fundamental and applied studies of product and process development of both established and emerging novel pharmaceutical modalities. Examples include large molecule, oligos, peptides, ADCs, gene therapy and other now modalities in pharmaceuticals. Scientists and engineers involved in upstream and downstream development, processing, scale-up and transfer of these products are invited. Topics may include, but not limited to, cell culture preparation/fermentation, separation/purification, formulation/buffer exchange, fill/finish and finished device/delivery.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Process Development Division (12)


Co-Chair:

Boung Wook Lee
Microbial & Cell Culture Development, GSK R&D, King of Prussia, PA

Abstract Submissions Closed